Breast Cancer Clinical Trials in Chicago

Showing 301-320 of 556 trials

Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer

NCT00003236

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of ISIS 5132 with ISIS 3521 in treating women who have metastatic breast cancer that has not responded to previous therapy.

Breast Cancer

Eastern Cooperative Oncology GroupStarted Jul 1998

Chicago, Illinois, United States • Chicago, Illinois, United States • Indianapolis, Indiana, United States +3 more locations

COMPLETED2.2 miles

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

NCT00003329

RATIONALE: Identification of genes that may be associated with developing certain types of cancer may someday provide important information about a person's risk of getting cancer. PURPOSE: This clinical trial is studying to see if certain genes may be associated with cancer in patients with cancer of the breast, prostate, lung, or colon and siblings of these patients.

Breast CancerColorectal CancerLung Cancer+1 more

Eastern Cooperative Oncology Group4,000 participantsStarted Apr 1998

Rancho Mirage, California, United States • Fort Collins, Colorado, United States • Boca Raton, Florida, United States +29 more locations

Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Breast Cancer Trials in Other Cities

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

TAC Versus TC for Adjuvant Breast Cancer

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)

Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer

Fulvestrant + Neratinib In Breast Cancer

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients

Other Conditions in Chicago